Mereo BioPharma Offered to Settle Proxy Contest with Rubric - GlobeNewswire

Retrieved on: 2022-09-26 11:01:37

Tags for this article:

Communication

Forward-looking statement

Mereo BioPharma Group plc

Rubric Capital Management LP

United Kingdom

Click the tags to see associated articles and topics

Mereo BioPharma Offered to Settle Proxy Contest with Rubric - GlobeNewswire. View article details on hiswai:

Excerpt

LONDON, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO), (“Mereo” or the “Company”), a clinical-stage biopharmaceutical ...

Article found on: www.globenewswire.com

View Original Article